血型鑑定产业的全球市场，预测到2028年

基本试剂和自动化的进步推动革命性变革并加速成长机会

这项研究概述了全球血型分型产业。由于社会意识增强、卫生基础设施改善、政府措施和人均收入增加等因素，预计将显着增长。镰状贫血、地中海贫血、淋巴瘤、白血病和血友病等血液相关疾病的盛行率不断增加，也支持了血型检测的发展。包括自动分析仪和抗球蛋白筛检工具在内的技术进步正在彻底改变临床结果并改善血液相容性。主要市场参与者正在优先考虑研发 (R&D) 投资，以提供创新设备、提高安全性、延长保质期并推动产业成长。在这个竞争环境中，策略伙伴关係和联盟变得越来越普遍，使产业参与企业能够扩大其产品范围并提高其全球影响力。

本研究按地区（北美、欧洲、亚太地区、世界其他地区）、测试类型（ABO 血液检测和 Rh 分型、抗体筛检、 HLA型检测、抗原分型等）和最终用户（医院、血液检测）分析数据。我们分析该行业的驱动因素和限制因素，并确定相关人员和市场相关人员可以利用该行业变化带来的成长机会。基准年为2023年，预测期间为2024年至2028年。

目录

概述

• 成长策略

策略要务

• 为什么成长如此困难？
• The Strategic Imperative 8（TM）
• 关键策略要务对全球血型分型产业的影响
• 成长机会推动Growth Pipeline Engine（TM）

成长机会分析

• 调查范围
• 考试类型细分
• 最终用户细分

血型分型 - 概述

• 成长指标
• 生长促进因子
• 成长抑制因素
• 预测假设
• 收益预测
• 收益预测分析
• 按地区分類的收益预测
• 按地区分類的收益预测分析 - 北美
• 按地区分類的收益预测分析 - 欧洲
• 按地区分類的收益预测分析 - 亚太地区
• 按地区分類的收益预测分析 - 世界其他地区
• 收益预测，按检查类型细分
• 按最终用户分類的收益预测
• 收益预测、最终用户分析
• 价格趋势与分析
• 主要定价策略（按玩家划分）
• 预计影响定价的因素
• 全球血型分型产业 - 值得注意的活动
• 各国血型分型报销途径
• 竞争环境

竞争格局

• 主要竞争对手/产业参与者
• 收益占有率，依玩家划分
• 每家公司的产品系列分析 - 按关键参数分類的产业参与者的竞争基准化分析

特色企业

• 特色企业

成长机会宇宙

• 成长机会 1：策略自动化整合彻底改变血型分型
• 成长机会 2：远端血型检测解决方案以增强可及性
• 成长机会 3：在服务欠缺地区扩大血型鑑定服务
• 成长机会4：与远端保健平台合作提供综合血型服务
• 成长机会概览

下一步

Advancements in Essential Reagents and Automation are Driving Revolutionary Change and Boosting Growth Opportunities

This study provides an overview of the global blood group typing industry, which is expected to witness significant growth, driven by factors like increased public awareness, improved healthcare infrastructure, government initiatives, and rising per capita income. The increasing prevalence of diseases associated with blood, such as sickle cell anemia, thalassemia, lymphoma, leukemia, and hemophilia, is also supporting the growth of blood group typing. Technological advances, including automated analyzers and antiglobulin screening tools, are revolutionizing clinical outcomes and enhancing blood compatibility. Major market players are prioritizing research and development (R&D) investments to offer innovative devices, improve safety, enhance storage duration, and promote industry growth. Strategic partnerships and alliances are becoming more popular in this competitive environment, allowing industry participants to broaden their product offerings and improve their worldwide presence.

The study offers relevant forecasts for this industry by region (North America, Europe, Asia-Pacific, and the rest of the world), test type (ABO blood tests & Rh typing, antibody screening, HLA typing, antigen typing, and others), and end users (hospitals, blood banks, clinical laboratories, and others). It analyzes the factors driving and restraining this industry and identifies the growth opportunities emerging from the changes in this space for stakeholders and market players to leverage. The base year is 2023, and the forecast period is from 2024 to 2028.

Table of Contents

Summary

• Growth Imperatives

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Global Blood Group Typing Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of the Study
• Test Type Segmentation
• End-user Segmentation

Blood Group Typing-Overview

• Growth Metrics
• Growth Drivers
• Growth Restraints
• Forecast Assumptions
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region-North America
• Revenue Forecast Analysis by Region-Europe
• Revenue Forecast Analysis by Region-Asia-Pacific
• Revenue Forecast Analysis by Region-RoW
• Revenue Forecast by Test Type Segment
• Revenue Forecast by End User
• Revenue Forecast by End User Analysis
• Pricing Trends and Analysis
• Key Pricing Strategies Adopted by Players
• Factors Expected to Influence Pricing
• Global Blood Group Typing Industry-Notable Activities
• Blood Group Typing Reimbursement Pathways by Country
• Competitive Environment

Competitive Landscape

• Key Competitors and Industry Players
• Revenue Share by Player
• Company Product Portfolio Analysis-Competitive Benchmarking of Industry Players by Key Parameter

Companies to Watch

• Companies to Watch

Growth Opportunity Universe

• Growth Opportunity 1: Strategic Automation Integration to Revolutionize Blood Group Testing
• Growth Opportunity 2: Remote Blood Group Testing Solutions for Enhanced Accessibility
• Growth Opportunity 3: Expansion of Blood Typing Services in Underserved Regions
• Growth Opportunity 4: Collaborations with Telehealth Platforms for Integrated Blood Group Services
• Growth Opportunity Summary

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer